Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05714982 · ClinicalTrials.gov registry record · NA
Impact of E-cigarette Device Warnings
A NA study of Vaping Behaviors, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 1,369
- Enrollment target
- 1
- Study location
NCT05714982 is a NA study of Vaping Behaviors that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 1,369 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05714982, a NA study of Vaping Behaviors, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,369 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this randomized clinical trial is to determine whether e-cigarette warnings increase intentions to quit vaping without the unintended consequence of pushing users toward smoking. This trial addresses these issues by evaluating the impact of e-cigarette warnings by randomly assigning vapers to have their devices and refills labeled with control messages, text warnings, or pictorial warnings. Participants will be US adult (ages 21+) vapers. The trial expects \~1,200 participants to complete Visits 1, 3, and 5.
Conditions Studied
Interventions
- OTHER Label with text health warning
- OTHER Label with pictorial health warning
- OTHER Label with neutral statements about vaping
Study Locations (1)
California
- Ewald & Wasserman Research Consultants, LLC - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,369 participants |
| Start Date | 2023-02-23 |
| Est. Completion | 2024-07-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05714982
The ClinicalTrials.gov registry entry for NCT05714982 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,369 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vaping Behaviors appearing as the primary indexed condition, and to 3 interventions - of which Label with text health warning is the first listed.
NCT05714982 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05714982 about?
NCT05714982 is a clinical study titled "Impact of E-cigarette Device Warnings". The purpose of this randomized clinical trial is to determine whether e-cigarette warnings increase intentions to quit vaping without the unintended consequence of pushing users toward smoking. This trial addresses these issues by evaluating the impact of e-cigarette warnings by randomly assigning v...
What is the current status of trial NCT05714982?
This trial is currently completed. It is a NA study. The enrollment target is 1,369 participants. The study started on 2023-02-23. Estimated completion is 2024-07-23.
What conditions does trial NCT05714982 study?
This clinical trial studies the following conditions: Vaping Behaviors.
What interventions are being tested in trial NCT05714982?
The interventions under investigation include: Label with text health warning (OTHER), Label with pictorial health warning (OTHER), Label with neutral statements about vaping (OTHER).
Who is sponsoring clinical trial NCT05714982?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05714982 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaping Behaviors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.